“…Some important examples are the anti-HIV drug Efavirenz (Staszewski et al, 1999) and the potent anticancer agent Maytansine (Rao et al, 1979) and its synthetic derivatives Maytansinoid (Blanc et al, 2011) and Ansamitocin P3 (Taft et al, 2012). Other significant biological activities described for this class of compounds are: antibacterial (Zanatta et al, 2006; Wang, 2008), anti-influenza (Kuznetsov et al, 2017), anti-inflammatory (Ullrich et al, 2004), antidiabetes [11β HSD1 inhibitor (BI 135585)] (Zhuang et al, 2017), antithrombotic (Jin and Confalone, 2000), antialzheimer (Fuchs et al, 2007), and enzyme inhibiting [(Latli et al, 2017); Figure 1]. Furthermore, they are extensively used as valuable synthetic intermediates in fine chemicals (Woodward et al, 1981; Wang et al, 1982; Hilborn et al, 2001; Takahata et al, 2002; Wang and Tunge, 2006), cosmetics (Zofchak, 2003), and pesticides (Hino et al, 2008).…”